Zweig-DiMenna Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$90.9M |
| 2 |
AGN
Allergan plc
AGN
|
+$50.4M |
| 3 |
CELG
Celgene Corp
CELG
|
+$48.9M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$40M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$39.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHI
Baker Hughes
BHI
|
+$34.4M |
| 2 |
Alibaba
BABA
|
+$25M |
| 3 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
+$23.5M |
| 4 |
Boeing
BA
|
+$19.8M |
| 5 |
Applied Materials
AMAT
|
+$18.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.17% |
| 2 | Consumer Discretionary | 12.92% |
| 3 | Communication Services | 9.83% |
| 4 | Technology | 8.92% |
| 5 | Consumer Staples | 7.38% |
Similar funds
Zweig-DiMenna Associates's Q3 2015 Portfolio in Review
As of Q3 2015, Zweig-DiMenna Associates held 324 positions worth $2.31B, up 27% from $1.81B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Zweig-DiMenna Associates deployed $761M of net new capital in Q3 2015, opening 77 new positions and adding to 76 existing holdings. Its largest new stake was Celgene Corp: 394,282 shares worth $42.6M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Baker Hughes, an estimated $34.4M trimmed.
- Zweig-DiMenna Associates's largest Q3 2015 buy was Celgene Corp: 394,282 shares worth $42.6M.
- Zweig-DiMenna Associates added most to Bristol-Myers Squibb in Q3 2015, an estimated $90.9M increase.
- Zweig-DiMenna Associates's biggest Q3 2015 reduction was Baker Hughes, cutting an estimated $34.4M.
- Zweig-DiMenna Associates fully exited Alibaba in Q3 2015, selling an estimated $25M.
- Zweig-DiMenna Associates's ten largest holdings make up 31% of its $2.31B portfolio in Q3 2015.
- Zweig-DiMenna Associates opened 77 new positions and closed 107 in Q3 2015.
- Zweig-DiMenna Associates's portfolio value rose 27% quarter-over-quarter to $2.31B.
Based on Zweig-DiMenna Associates's 13F filing for Q3 2015, filed 9 Nov 2015.